Rosalind Hastings


P2 Ros Hastings, Oxford University Hospitals, is the Scheme Organiser of the UK NEQAS for Clinical Cytogenetics and the Cytogenetics European Quality Assessment (CEQA) EQA schemes based at Oxford. Both EQA schemes cover constitutional and acquired cytogenetics including microarrays. In addition CEQA has an EQA for FISH based Pre-Implantation Genetic Diagnosis and is exploring offering a pilot PGD EQA using microarray technology. Both EQA schemes have participants predominantly from Europe but also Asia, South America, North America and Australasia.

UK NEQAS for Clinical Cytogenetics is an accredited EQA Scheme and CEQA has applied for accreditation status under ISO 17043.

Ros has past experience in research and diagnostic cytogenetics. She has been both Deputy Director and Head of Prenatal Sections in several laboratories within the UK. She is Chair of the ESHG Diagnostic Service Quality Committee whose main aim is to improve the quality and provision of Genetic services in Europe for the benefit of patients. She co-ordinates the ESHG Workshop on Diagnostic Cytogenetics held annually at the ESHG conference. In addition, she is one of the co-ordinators for the ECA Permanent Working Group on Cytogenetics and Society, and was co-author of the European Cytogenetic Guidelines.

  Email ros.hastingsouh.nhsuk
  Address CEQA and UK NEQAS for Clinical Cytogenetics
Level 2
Women's Centre
John Radcliffe Hospital, Oxford
University Hospitals NHS Trust
OX3 9DU Oxford
United Kingdom
  Telephone +44 1865 857644
  Fax +44 1865 857632
About EuroGentest
About Us
Standards Valid XHTML 1.0 Transitional Valid CSS!
European Union
Contact Information
Center for Human Genetics
University of Leuven
Herestraat 49 Box 602, 3000 Leuven, Belgium

Copyright EuroGentest2 Coordination Action 2011 - EU Contract no.: FP7 - HEALTH-F4-2010-261469